Serial 97099271
Live / Registered — Registered (as of 04 Mar 2025)
What this means for you
Registered since 04 Mar 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Mar 2031: the §8 declaration of use).
Record
- Serial number
- 97099271
- Registration number
- 7715568
- Mark type
- Design / logo
- Filed
- 29 Oct 2021
- Published for opposition
- 15 Feb 2022
- Registered
- 04 Mar 2025
- Next maintenance filing
- §8 declaration of use, due by 04 Mar 2031 (grace period to 04 Sept 2031)
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of inflammatory diseases and disorders
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Dec 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Oct 2024 — USE AMENDMENT FILED
- 16 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Oct 2024 — TEAS STATEMENT OF USE RECEIVED
- 20 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Mar 2024 — SOU EXTENSION 4 GRANTED